By Michele Maatouk
Date: Tuesday 05 Nov 2024
(Sharecast News) - AstraZeneca said on Tuesday that it does not comment on speculative media reports, in response to a sharp drop in its share price.
"As a matter of policy, we do not comment on speculative media reports including those related to ongoing investigations in China," the pharmaceuticals firm...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news